Budd-Chiari syndrome in a young female with factor V Leiden mutation: successful treatment with lepirudin, a direct thrombin inhibitor.
Salmela
Birgitta
B
Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
Nordin
Arno
A
Vuoristo
Matti
M
Mäkisalo
Heikki
H
Numminen
Kirsti
K
Lassila
Riitta
R
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D000991:Antithrombins / Q000008:administration & dosage*; D006502:Budd-Chiari Syndrome / Q000188:drug therapy* / Q000235:genetics*; D002764:Cholecystitis / Q000150:complications; D018450:Disease Progression; D004351:Drug Resistance; D064420:Drug-Related Side Effects and Adverse Reactions; D005165:Factor V / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D009154:Mutation; D016017:Odds Ratio; D011994:Recombinant Proteins / Q000008:administration & dosage; D019851:Thrombophilia / Q000150:complications / Q000235:genetics*; D016896:Treatment Outcome
D000925:Anticoagulants; D000991:Antithrombins; D006629:Hirudins; D011994:Recombinant Proteins; C095381:factor V Leiden; D005165:Factor V; C083544:lepirudin